News
Certificate / License
Shiner's MetaCu Capsules 300mg receives TFDA approval for patients of Wilson's Disease. (NDA, the orphan drug, API: trientine dihydrochloride)
Events
Shiner is entrusted with the development of a NCE for a tumor-related project.
Certificate / License
Shiner Zhunan Plant underwent an on-site inspection conducted by TFDA.
Events
Shiner enters into an exclusive supply and distribution agreement with a Dutch company for Class I medical products in the field of dermatology.
Certificate / License
Shiner Zhunan Plant is officially registered, and it's been recognized with a Green Building certification.
Events
Shiner signed an exclusive supply and distribution contract with a European company for orphan drugs.
Events
Shiner has taken on the project of developing a NCE for neurodegenerative diseases.
Events
Shiner announces a strategic partnership with a Swiss company for an innovative new ingredient in food products.
Certificate / License
Shiner's Reosteo 150mg Tablets receives TFDA approval. (NDA, new strengths, API: risedronate sodium)
Events